Skip to main content
Flerie AB logo

Flerie AB — Investor Relations & Filings

Ticker · FLERIE ISIN · SE0022447348 LEI · 54930047C4A74IBXR037 ST Financial and insurance activities
Open in API
Filings indexed 130 across all filing types
Latest filing 2026-05-05 Regulatory Filings
Country SE Sweden
Listing ST FLERIE

About Flerie AB

https://www.flerie.com/en/

Flerie AB is an active, long-term global investor in the life sciences sector. The company specializes in investing in and building companies with pioneering projects in biotechnology and pharmaceuticals. Its portfolio includes companies focused on drug development as well as those providing associated tools and services. Flerie leverages its network, expertise, and resources to support the long-term success and commercial growth of its portfolio companies, acting as a strategic partner.

Recent filings

Filing Released Lang Actions
NET ASSET VALUE – 30 April 2026
Regulatory Filings
2026-05-05 English
SUBSTANSVÄRDE – 30 april 2026
Regulatory Filings
2026-05-05 English
Förändring av det totala antalet aktier och röster i Flerie AB (publ)
Regulatory Filings
2026-04-30 Swedish
Change in the total number of shares and votes in Flerie AB (publ)
Regulatory Filings
2026-04-30 English
Styrelsen i Flerie beslutar om inlösen av aktier av serie C inom ramen för Fleries aktieinlösenprogram
Transaction in Own Shares Classification · 1% confidence The document is a press release announcing the board’s decision to redeem (repurchase and cancel) all class C shares under the company’s share redemption program, including details on record date, redemption price, and capital decrease. This constitutes a transaction in the company’s own shares (share repurchase/capital change), matching the “Transaction in Own Shares” category.
2026-04-15 Swedish
The Board of Directors of Flerie has resolved to redeem all Series C shares within the framework of Flerie’s share redemption scheme.
Share Issue/Capital Change Classification · 1% confidence The document is a press release from Flerie AB announcing the Board’s resolution to redeem all Series C shares, detailing redemption amounts, record date, and impact on share capital. This is an announcement of a share redemption (a capital change) rather than a full financial report, earnings release, or AGM material. It falls under announcements of share capital changes, so it matches the Share Issue/Capital Change category (SHA).
2026-04-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.